Literature DB >> 11943212

Phosphorylation of microtubule-associated protein tau by stress-activated protein kinases in intact cells.

Valérie Buée-Scherrer1, Michel Goedert.   

Abstract

Tau is a microtubule-associated protein that is abnormally hyperphosphorylated in the filamentous lesions that define a number of neurodegenerative diseases collectively referred to as tauopathies. We previously showed that stress-activated protein (SAP) kinases phosphorylate tau protein at many of the hyperphosphorylated sites in vitro. Here we have developed a system to study the effects of five SAP kinases (SAPK1c/JNK1, SAPK2a/p38alpha, SAPK2b/p38beta, SAPK3/p38gamma and SAPK4/p38delta) on tau phosphorylation in intact cells. All kinases phosphorylated tau, albeit at different efficiencies. Tau was a good substrate for SAPK3/p38gamma and SAPK4/p38delta, a reasonable substrate for SAPK2b/p38beta and a relatively poor substrate for SAPK2a/p38alpha and SAPK1c/JNK1. These findings indicate that the aberrant activation of SAP kinases, especially SAPK3/p38gamma and SAPK4/p38delta, could play an important role in the abnormal hyperphosphorylation of tau that is an invariant feature of the tauopathies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11943212     DOI: 10.1016/s0014-5793(02)02460-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  20 in total

1.  The p38 MAP Kinase Family as Regulators of Proinflammatory Cytokine Production in Degenerative Diseases of the CNS.

Authors:  Adam D Bachstetter; Linda J Van Eldik
Journal:  Aging Dis       Date:  2010-09-24       Impact factor: 6.745

2.  Targeting phospho-Ser422 by active Tau Immunotherapy in the THYTau22 mouse model: a suitable therapeutic approach.

Authors:  Laetitia Troquier; Raphaelle Caillierez; Sylvie Burnouf; Francisco J Fernandez-Gomez; Marie-Eve Grosjean; Nadege Zommer; Nicolas Sergeant; Susanna Schraen-Maschke; David Blum; Luc Buee
Journal:  Curr Alzheimer Res       Date:  2012-05       Impact factor: 3.498

3.  JNK signaling coordinates with ecdysone signaling to promote pruning of Drosophila sensory neuron dendrites.

Authors:  Sijun Zhu; Rui Chen; Peter Soba; Yuh-Nung Jan
Journal:  Development       Date:  2019-04-17       Impact factor: 6.868

4.  Inhibition of JNK by a peptide inhibitor reduces traumatic brain injury-induced tauopathy in transgenic mice.

Authors:  Hien T Tran; Laura Sanchez; David L Brody
Journal:  J Neuropathol Exp Neurol       Date:  2012-02       Impact factor: 3.685

5.  Stress kinases involved in tau phosphorylation in Alzheimer's disease, tauopathies and APP transgenic mice.

Authors:  I Ferrer
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

6.  An unbiased approach to identifying tau kinases that phosphorylate tau at sites associated with Alzheimer disease.

Authors:  Annalisa Cavallini; Suzanne Brewerton; Amanda Bell; Samantha Sargent; Sarah Glover; Clare Hardy; Roger Moore; John Calley; Devaki Ramachandran; Michael Poidinger; Eric Karran; Peter Davies; Michael Hutton; Philip Szekeres; Suchira Bose
Journal:  J Biol Chem       Date:  2013-06-24       Impact factor: 5.157

7.  Identification of glycogen synthase as a new substrate for stress-activated protein kinase 2b/p38beta.

Authors:  Yvonne Kuma; David G Campbell; Ana Cuenda
Journal:  Biochem J       Date:  2004-04-01       Impact factor: 3.857

Review 8.  p38 Mitogen-activated protein kinase regulates myelination.

Authors:  Jeffery D Haines; Gabriela Fragoso; Shireen Hossain; Walter E Mushynski; Guillermina Almazan
Journal:  J Mol Neurosci       Date:  2007-11-10       Impact factor: 3.444

9.  Phosphorylation of soluble tau differs in Pick's disease and Alzheimer's disease brains.

Authors:  Janet van Eersel; Mian Bi; Yazi D Ke; John R Hodges; John H Xuereb; Gillian C Gregory; Glenda M Halliday; Jürgen Götz; Jillian J Kril; Lars M Ittner
Journal:  J Neural Transm (Vienna)       Date:  2009-08-20       Impact factor: 3.575

Review 10.  p38 mitogen activated protein kinase as a therapeutic target for Alzheimer's disease.

Authors:  Stacie A Dalrymple
Journal:  J Mol Neurosci       Date:  2002-12       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.